PNNL-CompBio / earlyLateAMLresistance

Investigations into differences between early and late resistance in AML patients
MIT License
1 stars 2 forks source link

earlyLateAMLresistance

Investigations into differences between early and late resistance in AML patients. This repository describes the analysis required for two distinct projects.

The AML microenvironment catalyzes a step-wise evolution to gilteritinib resistance

This work is currently in press at Cancer Cell. The analysis can be found in this directory.

Stromal effects in patient data

There is new extension of this work focusing on the role of stroma in patient data in clinical trial. this analysis can be found in this directory.